The 2024-2025 mRNA COVID-19 vaccine provided moderate protection against severe outcomes, including hospitalizations and ED visits.

Long-acting injectable CAB+RPV maintains high virologic suppression in patients with HIV and obesity, showing comparable real-world efficacy.

Copilot Health can provide personalized health advice using a user’s medical data, if the user chooses to share it; the tool can review information such as test results, medical history, medications, ...

Receiving the COVID-19 vaccine and booster reduced preeclampsia risk by nearly 60% in pregnant patients with preexisting morbidities.

Federal regulators have warned the maker of Ozempic and Wegovy that it failed to report possible drug side effects to the government.

Injection drug use in the Appalachian region led to a significant syndemic of fatal overdoses and rising rates of HIV and viral hepatitis.

Chile has officially eliminated leprosy, becoming the first country in the Americas and only the second in the world to reach that milestone.

A fourth dose of bivalent or monovalent BA.1-adapted BNT162b2 vaccines was safe and elicited robust neutralizing responses in adults aged 18 to 55 years.

Maternal diabetes and being born large for gestational age are linked to a significantly higher risk for adult-onset multiple sclerosis in offspring.

Vitamin D does not change the 4-week incidence of health care utilization or COVID-19-related outcomes among adults with COVID-19.

Hospitalization for CAP was linked to a significantly increased risk of developing new NCDs over a 5-year period.

Postoperative infection in pediatric patients with CHD was associated with prolonged hospitalization and ICU stays.